orcinoside

Small moleculeexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2014 (NCT02191384)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • orcinoside
  • orcinoside

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02191384Phase 2Jul 1, 2014Jiao Tong University, Kun Ming KingBio Biotechnology Co. LTD
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Jiao Tong UniversityAcademic/Hospital1112014
Kun Ming KingBio Biotechnology Co. LTDGovernment1012014
2 organizations
Page 1 / 1